Global Poultry Coccidiosis Vaccines Market Growth 2026-2032

June 2026 | 125 pages | ID: GD11006A6B46EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Poultry Coccidiosis Vaccines market size is predicted to grow from US$ 127 million in 2025 to US$ 166 million in 2032; it is expected to grow at a CAGR of 4.0% from 2026 to 2032.

Poultry Coccidiosis Vaccines are specialized vaccines designed to prevent coccidiosis in poultry, a parasitic disease caused by protozoa such as Eimeria species that infect the intestinal tract of chickens, turkeys, and other poultry. These vaccines stimulate the immune system of poultry to develop resistance against coccidiosis, effectively reducing disease incidence and improving growth performance and feed conversion rates. Poultry coccidiosis vaccines are a crucial tool for controlling this disease and offer a safer and more environmentally friendly alternative to traditional anticoccidial drugs, with the added benefit of reducing the risk of drug resistance. They are widely used in modern intensive poultry farming.

United States market for Poultry Coccidiosis Vaccines is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Poultry Coccidiosis Vaccines is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Poultry Coccidiosis Vaccines is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Poultry Coccidiosis Vaccines players cover MSD Animal Health, Boehringer Ingelheim, HIPRA, Bioproperties, Huvepharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Poultry Coccidiosis Vaccines Industry Forecast? looks at past sales and reviews total world Poultry Coccidiosis Vaccines sales in 2025, providing a comprehensive analysis by region and market sector of projected Poultry Coccidiosis Vaccines sales for 2026 through 2032. With Poultry Coccidiosis Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Poultry Coccidiosis Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Poultry Coccidiosis Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Poultry Coccidiosis Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Poultry Coccidiosis Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Poultry Coccidiosis Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Poultry Coccidiosis Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Poultry Coccidiosis Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Attenuated Vaccines
  • Non-attenuated Vaccines
Segmentation by Application:
  • Poultry
  • Other Animals
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • MSD Animal Health
  • Boehringer Ingelheim
  • HIPRA
  • Bioproperties
  • Huvepharma
  • Nisseiken
  • Biopharm
  • Ceva Sant? Animale
  • Vaxxinova
  • Foshan Standard Biotech
  • Qilu Qingda Bio-Pharmaceutical
  • Skystar Bio-pharm
  • Hlinte
  • Guangdong Winsun Bio-pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Poultry Coccidiosis Vaccines market?
What factors are driving Poultry Coccidiosis Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Poultry Coccidiosis Vaccines market opportunities vary by end market size?
How does Poultry Coccidiosis Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Poultry Coccidiosis Vaccines Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Poultry Coccidiosis Vaccines by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Poultry Coccidiosis Vaccines by Country/Region, 2021, 2025 & 2032
2.2 Poultry Coccidiosis Vaccines Segment by Type
  2.2.1 Attenuated Vaccines
  2.2.2 Non-attenuated Vaccines
  2.2.3 Poultry Coccidiosis Vaccines Sales by Type
    2.2.3.1 Global Poultry Coccidiosis Vaccines Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Poultry Coccidiosis Vaccines Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Poultry Coccidiosis Vaccines Sale Price by Type (2021-2026)
2.3 Poultry Coccidiosis Vaccines Segment by Application
  2.3.1 Poultry
  2.3.2 Other Animals
  2.3.3 Poultry Coccidiosis Vaccines Sales by Application
    2.3.3.1 Global Poultry Coccidiosis Vaccines Sale Market Share by Application (2021-2026)
    2.3.3.2 Global Poultry Coccidiosis Vaccines Revenue and Market Share by Application (2021-2026)
    2.3.3.3 Global Poultry Coccidiosis Vaccines Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Poultry Coccidiosis Vaccines Breakdown Data by Company
  3.1.1 Global Poultry Coccidiosis Vaccines Annual Sales by Company (2021-2026)
  3.1.2 Global Poultry Coccidiosis Vaccines Sales Market Share by Company (2021-2026)
3.2 Global Poultry Coccidiosis Vaccines Annual Revenue by Company (2021-2026)
  3.2.1 Global Poultry Coccidiosis Vaccines Revenue by Company (2021-2026)
  3.2.2 Global Poultry Coccidiosis Vaccines Revenue Market Share by Company (2021-2026)
3.3 Global Poultry Coccidiosis Vaccines Sale Price by Company
3.4 Key Manufacturers Poultry Coccidiosis Vaccines Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Poultry Coccidiosis Vaccines Product Location Distribution
  3.4.2 Players Poultry Coccidiosis Vaccines Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR POULTRY COCCIDIOSIS VACCINES BY GEOGRAPHIC REGION

4.1 World Historic Poultry Coccidiosis Vaccines Market Size by Geographic Region (2021-2026)
  4.1.1 Global Poultry Coccidiosis Vaccines Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Poultry Coccidiosis Vaccines Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Poultry Coccidiosis Vaccines Market Size by Country/Region (2021-2026)
  4.2.1 Global Poultry Coccidiosis Vaccines Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Poultry Coccidiosis Vaccines Annual Revenue by Country/Region (2021-2026)
4.3 Americas Poultry Coccidiosis Vaccines Sales Growth
4.4 APAC Poultry Coccidiosis Vaccines Sales Growth
4.5 Europe Poultry Coccidiosis Vaccines Sales Growth
4.6 Middle East & Africa Poultry Coccidiosis Vaccines Sales Growth

5 AMERICAS

5.1 Americas Poultry Coccidiosis Vaccines Sales by Country
  5.1.1 Americas Poultry Coccidiosis Vaccines Sales by Country (2021-2026)
  5.1.2 Americas Poultry Coccidiosis Vaccines Revenue by Country (2021-2026)
5.2 Americas Poultry Coccidiosis Vaccines Sales by Type (2021-2026)
5.3 Americas Poultry Coccidiosis Vaccines Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Poultry Coccidiosis Vaccines Sales by Region
  6.1.1 APAC Poultry Coccidiosis Vaccines Sales by Region (2021-2026)
  6.1.2 APAC Poultry Coccidiosis Vaccines Revenue by Region (2021-2026)
6.2 APAC Poultry Coccidiosis Vaccines Sales by Type (2021-2026)
6.3 APAC Poultry Coccidiosis Vaccines Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Poultry Coccidiosis Vaccines by Country
  7.1.1 Europe Poultry Coccidiosis Vaccines Sales by Country (2021-2026)
  7.1.2 Europe Poultry Coccidiosis Vaccines Revenue by Country (2021-2026)
7.2 Europe Poultry Coccidiosis Vaccines Sales by Type (2021-2026)
7.3 Europe Poultry Coccidiosis Vaccines Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Poultry Coccidiosis Vaccines by Country
  8.1.1 Middle East & Africa Poultry Coccidiosis Vaccines Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Poultry Coccidiosis Vaccines Revenue by Country (2021-2026)
8.2 Middle East & Africa Poultry Coccidiosis Vaccines Sales by Type (2021-2026)
8.3 Middle East & Africa Poultry Coccidiosis Vaccines Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Poultry Coccidiosis Vaccines
10.3 Manufacturing Process Analysis of Poultry Coccidiosis Vaccines
10.4 Industry Chain Structure of Poultry Coccidiosis Vaccines

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Poultry Coccidiosis Vaccines Distributors
11.3 Poultry Coccidiosis Vaccines Customer

12 WORLD FORECAST REVIEW FOR POULTRY COCCIDIOSIS VACCINES BY GEOGRAPHIC REGION

12.1 Global Poultry Coccidiosis Vaccines Market Size Forecast by Region
  12.1.1 Global Poultry Coccidiosis Vaccines Forecast by Region (2027-2032)
  12.1.2 Global Poultry Coccidiosis Vaccines Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Poultry Coccidiosis Vaccines Forecast by Type (2027-2032)
12.7 Global Poultry Coccidiosis Vaccines Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 MSD Animal Health
  13.1.1 MSD Animal Health Company Information
  13.1.2 MSD Animal Health Poultry Coccidiosis Vaccines Product Portfolios and Specifications
  13.1.3 MSD Animal Health Poultry Coccidiosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 MSD Animal Health Main Business Overview
  13.1.5 MSD Animal Health Latest Developments
13.2 Boehringer Ingelheim
  13.2.1 Boehringer Ingelheim Company Information
  13.2.2 Boehringer Ingelheim Poultry Coccidiosis Vaccines Product Portfolios and Specifications
  13.2.3 Boehringer Ingelheim Poultry Coccidiosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Boehringer Ingelheim Main Business Overview
  13.2.5 Boehringer Ingelheim Latest Developments
13.3 HIPRA
  13.3.1 HIPRA Company Information
  13.3.2 HIPRA Poultry Coccidiosis Vaccines Product Portfolios and Specifications
  13.3.3 HIPRA Poultry Coccidiosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 HIPRA Main Business Overview
  13.3.5 HIPRA Latest Developments
13.4 Bioproperties
  13.4.1 Bioproperties Company Information
  13.4.2 Bioproperties Poultry Coccidiosis Vaccines Product Portfolios and Specifications
  13.4.3 Bioproperties Poultry Coccidiosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Bioproperties Main Business Overview
  13.4.5 Bioproperties Latest Developments
13.5 Huvepharma
  13.5.1 Huvepharma Company Information
  13.5.2 Huvepharma Poultry Coccidiosis Vaccines Product Portfolios and Specifications
  13.5.3 Huvepharma Poultry Coccidiosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Huvepharma Main Business Overview
  13.5.5 Huvepharma Latest Developments
13.6 Nisseiken
  13.6.1 Nisseiken Company Information
  13.6.2 Nisseiken Poultry Coccidiosis Vaccines Product Portfolios and Specifications
  13.6.3 Nisseiken Poultry Coccidiosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Nisseiken Main Business Overview
  13.6.5 Nisseiken Latest Developments
13.7 Biopharm
  13.7.1 Biopharm Company Information
  13.7.2 Biopharm Poultry Coccidiosis Vaccines Product Portfolios and Specifications
  13.7.3 Biopharm Poultry Coccidiosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Biopharm Main Business Overview
  13.7.5 Biopharm Latest Developments
13.8 Ceva Sante Animale
  13.8.1 Ceva Sante Animale Company Information
  13.8.2 Ceva Sante Animale Poultry Coccidiosis Vaccines Product Portfolios and Specifications
  13.8.3 Ceva Sante Animale Poultry Coccidiosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Ceva Sante Animale Main Business Overview
  13.8.5 Ceva Sante Animale Latest Developments
13.9 Vaxxinova
  13.9.1 Vaxxinova Company Information
  13.9.2 Vaxxinova Poultry Coccidiosis Vaccines Product Portfolios and Specifications
  13.9.3 Vaxxinova Poultry Coccidiosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Vaxxinova Main Business Overview
  13.9.5 Vaxxinova Latest Developments
13.10 Foshan Standard Biotech
  13.10.1 Foshan Standard Biotech Company Information
  13.10.2 Foshan Standard Biotech Poultry Coccidiosis Vaccines Product Portfolios and Specifications
  13.10.3 Foshan Standard Biotech Poultry Coccidiosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Foshan Standard Biotech Main Business Overview
  13.10.5 Foshan Standard Biotech Latest Developments
13.11 Qilu Qingda Bio-Pharmaceutical
  13.11.1 Qilu Qingda Bio-Pharmaceutical Company Information
  13.11.2 Qilu Qingda Bio-Pharmaceutical Poultry Coccidiosis Vaccines Product Portfolios and Specifications
  13.11.3 Qilu Qingda Bio-Pharmaceutical Poultry Coccidiosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Qilu Qingda Bio-Pharmaceutical Main Business Overview
  13.11.5 Qilu Qingda Bio-Pharmaceutical Latest Developments
13.12 Skystar Bio-pharm
  13.12.1 Skystar Bio-pharm Company Information
  13.12.2 Skystar Bio-pharm Poultry Coccidiosis Vaccines Product Portfolios and Specifications
  13.12.3 Skystar Bio-pharm Poultry Coccidiosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Skystar Bio-pharm Main Business Overview
  13.12.5 Skystar Bio-pharm Latest Developments
13.13 Hlinte
  13.13.1 Hlinte Company Information
  13.13.2 Hlinte Poultry Coccidiosis Vaccines Product Portfolios and Specifications
  13.13.3 Hlinte Poultry Coccidiosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Hlinte Main Business Overview
  13.13.5 Hlinte Latest Developments
13.14 Guangdong Winsun Bio-pharmaceutical
  13.14.1 Guangdong Winsun Bio-pharmaceutical Company Information
  13.14.2 Guangdong Winsun Bio-pharmaceutical Poultry Coccidiosis Vaccines Product Portfolios and Specifications
  13.14.3 Guangdong Winsun Bio-pharmaceutical Poultry Coccidiosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 Guangdong Winsun Bio-pharmaceutical Main Business Overview
  13.14.5 Guangdong Winsun Bio-pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Poultry Coccidiosis Vaccines Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Poultry Coccidiosis Vaccines Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Attenuated Vaccines
Table 4. Major Players of Non-attenuated Vaccines
Table 5. Global Poultry Coccidiosis Vaccines Sales by Type (2021-2026) & (K Units)
Table 6. Global Poultry Coccidiosis Vaccines Sales Market Share by Type (2021-2026)
Table 7. Global Poultry Coccidiosis Vaccines Revenue by Type (2021-2026) & ($ million)
Table 8. Global Poultry Coccidiosis Vaccines Revenue Market Share by Type (2021-2026)
Table 9. Global Poultry Coccidiosis Vaccines Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Poultry Coccidiosis Vaccines Sale by Application (2021-2026) & (K Units)
Table 11. Global Poultry Coccidiosis Vaccines Sale Market Share by Application (2021-2026)
Table 12. Global Poultry Coccidiosis Vaccines Revenue by Application (2021-2026) & ($ million)
Table 13. Global Poultry Coccidiosis Vaccines Revenue Market Share by Application (2021-2026)
Table 14. Global Poultry Coccidiosis Vaccines Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Poultry Coccidiosis Vaccines Sales by Company (2021-2026) & (K Units)
Table 16. Global Poultry Coccidiosis Vaccines Sales Market Share by Company (2021-2026)
Table 17. Global Poultry Coccidiosis Vaccines Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Poultry Coccidiosis Vaccines Revenue Market Share by Company (2021-2026)
Table 19. Global Poultry Coccidiosis Vaccines Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Poultry Coccidiosis Vaccines Producing Area Distribution and Sales Area
Table 21. Players Poultry Coccidiosis Vaccines Products Offered
Table 22. Poultry Coccidiosis Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Poultry Coccidiosis Vaccines Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Poultry Coccidiosis Vaccines Sales Market Share Geographic Region (2021-2026)
Table 27. Global Poultry Coccidiosis Vaccines Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Poultry Coccidiosis Vaccines Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Poultry Coccidiosis Vaccines Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Poultry Coccidiosis Vaccines Sales Market Share by Country/Region (2021-2026)
Table 31. Global Poultry Coccidiosis Vaccines Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Poultry Coccidiosis Vaccines Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Poultry Coccidiosis Vaccines Sales by Country (2021-2026) & (K Units)
Table 34. Americas Poultry Coccidiosis Vaccines Sales Market Share by Country (2021-2026)
Table 35. Americas Poultry Coccidiosis Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Poultry Coccidiosis Vaccines Sales by Type (2021-2026) & (K Units)
Table 37. Americas Poultry Coccidiosis Vaccines Sales by Application (2021-2026) & (K Units)
Table 38. APAC Poultry Coccidiosis Vaccines Sales by Region (2021-2026) & (K Units)
Table 39. APAC Poultry Coccidiosis Vaccines Sales Market Share by Region (2021-2026)
Table 40. APAC Poultry Coccidiosis Vaccines Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Poultry Coccidiosis Vaccines Sales by Type (2021-2026) & (K Units)
Table 42. APAC Poultry Coccidiosis Vaccines Sales by Application (2021-2026) & (K Units)
Table 43. Europe Poultry Coccidiosis Vaccines Sales by Country (2021-2026) & (K Units)
Table 44. Europe Poultry Coccidiosis Vaccines Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Poultry Coccidiosis Vaccines Sales by Type (2021-2026) & (K Units)
Table 46. Europe Poultry Coccidiosis Vaccines Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Poultry Coccidiosis Vaccines Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Poultry Coccidiosis Vaccines Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Poultry Coccidiosis Vaccines Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Poultry Coccidiosis Vaccines Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Poultry Coccidiosis Vaccines
Table 52. Key Market Challenges & Risks of Poultry Coccidiosis Vaccines
Table 53. Key Industry Trends of Poultry Coccidiosis Vaccines
Table 54. Poultry Coccidiosis Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Poultry Coccidiosis Vaccines Distributors List
Table 57. Poultry Coccidiosis Vaccines Customer List
Table 58. Global Poultry Coccidiosis Vaccines Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Poultry Coccidiosis Vaccines Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Poultry Coccidiosis Vaccines Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Poultry Coccidiosis Vaccines Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Poultry Coccidiosis Vaccines Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Poultry Coccidiosis Vaccines Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Poultry Coccidiosis Vaccines Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Poultry Coccidiosis Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Poultry Coccidiosis Vaccines Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Poultry Coccidiosis Vaccines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Poultry Coccidiosis Vaccines Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Poultry Coccidiosis Vaccines Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Poultry Coccidiosis Vaccines Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Poultry Coccidiosis Vaccines Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. MSD Animal Health Basic Information, Poultry Coccidiosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. MSD Animal Health Poultry Coccidiosis Vaccines Product Portfolios and Specifications
Table 74. MSD Animal Health Poultry Coccidiosis Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. MSD Animal Health Main Business
Table 76. MSD Animal Health Latest Developments
Table 77. Boehringer Ingelheim Basic Information, Poultry Coccidiosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. Boehringer Ingelheim Poultry Coccidiosis Vaccines Product Portfolios and Specifications
Table 79. Boehringer Ingelheim Poultry Coccidiosis Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Latest Developments
Table 82. HIPRA Basic Information, Poultry Coccidiosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. HIPRA Poultry Coccidiosis Vaccines Product Portfolios and Specifications
Table 84. HIPRA Poultry Coccidiosis Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. HIPRA Main Business
Table 86. HIPRA Latest Developments
Table 87. Bioproperties Basic Information, Poultry Coccidiosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Bioproperties Poultry Coccidiosis Vaccines Product Portfolios and Specifications
Table 89. Bioproperties Poultry Coccidiosis Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Bioproperties Main Business
Table 91. Bioproperties Latest Developments
Table 92. Huvepharma Basic Information, Poultry Coccidiosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Huvepharma Poultry Coccidiosis Vaccines Product Portfolios and Specifications
Table 94. Huvepharma Poultry Coccidiosis Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Huvepharma Main Business
Table 96. Huvepharma Latest Developments
Table 97. Nisseiken Basic Information, Poultry Coccidiosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Nisseiken Poultry Coccidiosis Vaccines Product Portfolios and Specifications
Table 99. Nisseiken Poultry Coccidiosis Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Nisseiken Main Business
Table 101. Nisseiken Latest Developments
Table 102. Biopharm Basic Information, Poultry Coccidiosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Biopharm Poultry Coccidiosis Vaccines Product Portfolios and Specifications
Table 104. Biopharm Poultry Coccidiosis Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Biopharm Main Business
Table 106. Biopharm Latest Developments
Table 107. Ceva Sant? Animale Basic Information, Poultry Coccidiosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Ceva Sant? Animale Poultry Coccidiosis Vaccines Product Portfolios and Specifications
Table 109. Ceva Sant? Animale Poultry Coccidiosis Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Ceva Sant? Animale Main Business
Table 111. Ceva Sant? Animale Latest Developments
Table 112. Vaxxinova Basic Information, Poultry Coccidiosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. Vaxxinova Poultry Coccidiosis Vaccines Product Portfolios and Specifications
Table 114. Vaxxinova Poultry Coccidiosis Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Vaxxinova Main Business
Table 116. Vaxxinova Latest Developments
Table 117. Foshan Standard Biotech Basic Information, Poultry Coccidiosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. Foshan Standard Biotech Poultry Coccidiosis Vaccines Product Portfolios and Specifications
Table 119. Foshan Standard Biotech Poultry Coccidiosis Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Foshan Standard Biotech Main Business
Table 121. Foshan Standard Biotech Latest Developments
Table 122. Qilu Qingda Bio-Pharmaceutical Basic Information, Poultry Coccidiosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Qilu Qingda Bio-Pharmaceutical Poultry Coccidiosis Vaccines Product Portfolios and Specifications
Table 124. Qilu Qingda Bio-Pharmaceutical Poultry Coccidiosis Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Qilu Qingda Bio-Pharmaceutical Main Business
Table 126. Qilu Qingda Bio-Pharmaceutical Latest Developments
Table 127. Skystar Bio-pharm Basic Information, Poultry Coccidiosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. Skystar Bio-pharm Poultry Coccidiosis Vaccines Product Portfolios and Specifications
Table 129. Skystar Bio-pharm Poultry Coccidiosis Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Skystar Bio-pharm Main Business
Table 131. Skystar Bio-pharm Latest Developments
Table 132. Hlinte Basic Information, Poultry Coccidiosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Hlinte Poultry Coccidiosis Vaccines Product Portfolios and Specifications
Table 134. Hlinte Poultry Coccidiosis Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Hlinte Main Business
Table 136. Hlinte Latest Developments
Table 137. Guangdong Winsun Bio-pharmaceutical Basic Information, Poultry Coccidiosis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 138. Guangdong Winsun Bio-pharmaceutical Poultry Coccidiosis Vaccines Product Portfolios and Specifications
Table 139. Guangdong Winsun Bio-pharmaceutical Poultry Coccidiosis Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Guangdong Winsun Bio-pharmaceutical Main Business
Table 141. Guangdong Winsun Bio-pharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Picture of Poultry Coccidiosis Vaccines
Figure 2. Poultry Coccidiosis Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Poultry Coccidiosis Vaccines Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Poultry Coccidiosis Vaccines Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Poultry Coccidiosis Vaccines Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Poultry Coccidiosis Vaccines Sales Market Share by Country/Region (2025)
Figure 10. Poultry Coccidiosis Vaccines Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Attenuated Vaccines
Figure 12. Product Picture of Non-attenuated Vaccines
Figure 13. Global Poultry Coccidiosis Vaccines Sales Market Share by Type in 2026
Figure 14. Global Poultry Coccidiosis Vaccines Revenue Market Share by Type (2021-2026)
Figure 15. Poultry Coccidiosis Vaccines Consumed in Poultry
Figure 16. Global Poultry Coccidiosis Vaccines Market: Poultry (2021-2026) & (K Units)
Figure 17. Poultry Coccidiosis Vaccines Consumed in Other Animals
Figure 18. Global Poultry Coccidiosis Vaccines Market: Other Animals (2021-2026) & (K Units)
Figure 19. Global Poultry Coccidiosis Vaccines Sale Market Share by Application (2025)
Figure 20. Global Poultry Coccidiosis Vaccines Revenue Market Share by Application in 2026
Figure 21. Poultry Coccidiosis Vaccines Sales by Company in 2026 (K Units)
Figure 22. Global Poultry Coccidiosis Vaccines Sales Market Share by Company in 2026
Figure 23. Poultry Coccidiosis Vaccines Revenue by Company in 2026 ($ millions)
Figure 24. Global Poultry Coccidiosis Vaccines Revenue Market Share by Company in 2026
Figure 25. Global Poultry Coccidiosis Vaccines Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Poultry Coccidiosis Vaccines Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Poultry Coccidiosis Vaccines Sales 2021-2026 (K Units)
Figure 28. Americas Poultry Coccidiosis Vaccines Revenue 2021-2026 ($ millions)
Figure 29. APAC Poultry Coccidiosis Vaccines Sales 2021-2026 (K Units)
Figure 30. APAC Poultry Coccidiosis Vaccines Revenue 2021-2026 ($ millions)
Figure 31. Europe Poultry Coccidiosis Vaccines Sales 2021-2026 (K Units)
Figure 32. Europe Poultry Coccidiosis Vaccines Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Poultry Coccidiosis Vaccines Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Poultry Coccidiosis Vaccines Revenue 2021-2026 ($ millions)
Figure 35. Americas Poultry Coccidiosis Vaccines Sales Market Share by Country in 2026
Figure 36. Americas Poultry Coccidiosis Vaccines Revenue Market Share by Country (2021-2026)
Figure 37. Americas Poultry Coccidiosis Vaccines Sales Market Share by Type (2021-2026)
Figure 38. Americas Poultry Coccidiosis Vaccines Sales Market Share by Application (2021-2026)
Figure 39. United States Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Poultry Coccidiosis Vaccines Sales Market Share by Region in 2026
Figure 44. APAC Poultry Coccidiosis Vaccines Revenue Market Share by Region (2021-2026)
Figure 45. APAC Poultry Coccidiosis Vaccines Sales Market Share by Type (2021-2026)
Figure 46. APAC Poultry Coccidiosis Vaccines Sales Market Share by Application (2021-2026)
Figure 47. China Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 51. India Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Poultry Coccidiosis Vaccines Sales Market Share by Country in 2026
Figure 55. Europe Poultry Coccidiosis Vaccines Revenue Market Share by Country (2021-2026)
Figure 56. Europe Poultry Coccidiosis Vaccines Sales Market Share by Type (2021-2026)
Figure 57. Europe Poultry Coccidiosis Vaccines Sales Market Share by Application (2021-2026)
Figure 58. Germany Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 59. France Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Poultry Coccidiosis Vaccines Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Poultry Coccidiosis Vaccines Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Poultry Coccidiosis Vaccines Sales Market Share by Application (2021-2026)
Figure 66. Egypt Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Poultry Coccidiosis Vaccines Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Poultry Coccidiosis Vaccines in 2026
Figure 72. Manufacturing Process Analysis of Poultry Coccidiosis Vaccines
Figure 73. Industry Chain Structure of Poultry Coccidiosis Vaccines
Figure 74. Channels of Distribution
Figure 75. Global Poultry Coccidiosis Vaccines Sales Market Forecast by Region (2027-2032)
Figure 76. Global Poultry Coccidiosis Vaccines Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Poultry Coccidiosis Vaccines Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Poultry Coccidiosis Vaccines Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Poultry Coccidiosis Vaccines Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Poultry Coccidiosis Vaccines Revenue Market Share Forecast by Application (2027-2032)


More Publications